virus

April 28, 2014

Target cell entry to halt Chikungunya virus

Understanding how chikungunya virus binds to and enters cells offers a new target for antiviral medications.

By Leigh MacMillan
May 16, 2013

Grant targets new therapies for Ebola, Marburg viruses

Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses.

By VUMC News and Communications
April 26, 2013

Factor reduces virus-related asthma attacks

An immune system factor associated with severe asthma may actually reduce asthma attacks induced by viral infections.

By Leigh MacMillan
December 7, 2012

Breast milk blocks virus binding

Components of human breast milk help ward off viral infection, a new study shows.

By VUMC News and Communications
October 31, 2012

Protein’s length, flexibility key to infection

The structural architecture of the reovirus attachment protein is required for efficient reovirus infection of host cells.

By Leigh MacMillan
October 5, 2012

Host proteins can control HIV infection

The protein APOBEC3G contributes to spontaneous control of HIV-1 in vivo and may provide therapeutic benefits.

By Leigh MacMillan
September 25, 2012

Cell entry ports for cold virus

The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells.
By Leigh MacMillan
August 9, 2012

New therapeutic target for cold, flu viruses identified

Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs. Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells.
By Leigh MacMillan
April 13, 2012

Researchers spot Achilles’ heel in respiratory virus

A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults.
By Leigh MacMillan
February 15, 2012

On the tail of RSV infection mechanism

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.
By VUMC News and Communications
October 7, 2011

Diversity key in antibody repertoire

Antibodies to the 2009 H1N1 influenza strain reveal new insights into how antibody diversity forms and functions, with possible implications for designing flu vaccines.
By VUMC News and Communications
1 2